This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Kuraray Co., Ltd.. Active years: 1983-1997.
Company Filing History:
Years Active: 1983-1997
Title: Etsuko Abe: Innovator in Cancer Treatment
Introduction
Etsuko Abe is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical science, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative methods to combat leukemia and other leukemoid diseases.
Latest Patents
Etsuko Abe's latest patents include a peptide or its salts that exhibit high binding activity for human interleukin-1. This peptide is represented by a specific formula that enhances its effectiveness. Additionally, she has developed a method for treating leukemia or leukemoid diseases through the administration of a vitamin D derivative with a hydroxyl group at the 1.alpha.-position. This method is believed to facilitate the redifferentiation of cancer cells, showcasing the potential of vitamin D derivatives in cancer therapy.
Career Highlights
Throughout her career, Etsuko Abe has worked with notable companies such as Chugai Seiyaku Kabushiki Kaisha and Kuraray Co., Ltd. Her experience in these organizations has contributed to her expertise in the field of medical innovations.
Collaborations
Etsuko has collaborated with esteemed colleagues, including Tatsuo Suda and Yoshihei Hirasawa. These partnerships have further enriched her research and development efforts.
Conclusion
Etsuko Abe's innovative work in cancer treatment exemplifies her dedication to advancing medical science. Her patents and collaborations highlight her significant impact in the field, paving the way for future breakthroughs in leukemia treatment.